Stephen M Larson, DMD | |
6411 Fannin St, Houston, TX 77030-1501 | |
(713) 500-6200 | |
(713) 500-6201 |
Full Name | Stephen M Larson |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 6411 Fannin St, Houston, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003838459 | NPI | - | NPPES |
8X6137 | Other | TX | BCBS |
102216202 | Medicaid | TX | |
84214F | Other | TX | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 11353 (Texas) | Secondary |
1223G0001X | Dentist - General Practice | 11353 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephen M Larson, DMD Po Box 301173, Dallas, TX 75303-1173 Ph: (713) 500-3500 | Stephen M Larson, DMD 6411 Fannin St, Houston, TX 77030-1501 Ph: (713) 500-6200 |
News Archive
Results from a study published in the Journal of Internal Medicine suggest that bacterial infections may elevate the risk of coronary heart disease in individuals with type 1 diabetes.
Novel treatment strategies for major depression with broader treatment success or a more rapid onset of action would have immense impact on public health, a new study published in the December 1st issue of Biological Psychiatry explains.
The new health law's requirement that young adults be able to remain on their parents' health plans until they turn 26, is raising some questions from hopeful parents: "when exactly the new benefit begins, who exactly is eligible and who decides." But the answer to all those is: "It depends. ... the decision about when to start the new benefit is being made by lots of different players in the health system.
Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Yale scientists have enlisted a most unlikely ally in efforts to treat this form of cancer - elements of the Ebola virus.
Emerging Healthcare Solutions, Inc. announced today that management has formally delivered an actionable Term Sheet to ThromboVision for review and that follow up communications have been very favorable.
› Verified 1 days ago